Company / Total Assets
SANGAMO THERAPEUTICS, INC Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$59.7M
FY2025
5-year range
$59.7M / $721.9M
FY2021-FY2025
Trend
-41.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 5 consecutive years, from $939M in FY2020 to $60M in FY2025.
Based on SEC 10-K filings.
$60M in FY2025 with a 5-year CAGR of -42.4%.
Declined from $165M to $60M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -52.6%
- 5-Year CAGR
- -42.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- SANGAMO THERAPEUTICS, INC's total assets has declined for 5 consecutive years.
- 5-year CAGR of -42.4%, indicating a declining trend.
- In FY2025, total assets decreased 41.2% year-over-year.
- Peak total assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -28.87 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $59.7M | -41.2% |
| FY2024 | $101.6M | -38.5% |
| FY2023 | $165.3M | -70.6% |
| FY2022 | $562.5M | -22.1% |
| FY2021 | $721.9M | -23.1% |
| FY2020 | $938.5M | +47.2% |
| FY2019 | $637.5M | +8.0% |
| FY2018 | $590.4M | +105.9% |
| FY2017 | $286.7M | +81.6% |
| FY2016 | $157.9M | -27.3% |